Leuconostoc bacteremia in pediatric patients with short bowel syndrome

Diana F Florescu, Lisa Hill, Debra Sudan, Peter Charles Iwen

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

INTRODUCTION: Infections caused by Leuconostoc species are rare with most reported cases occurring in immunocompromised patients. This article presents 6 new cases of pediatric patients with short bowel syndrome who developed Leuconostoc bacteremia, and compares these cases with those previously reported in the literature. MATERIALS AND METHODS: This is a retrospective, descriptive study (January 2001 to May 2007) performed in a tertiary care teaching center. Hospitalized patients younger than 18 years of age, with multiple positive blood cultures for Leuconostoc spp. were evaluated. The collected data were compared with 10 similar previously reported cases. RESULTS: Six new cases of pediatric patients with short bowel syndrome who developed Leuconostoc bacteremia were identified. All 6 patients had received total parenteral nutrition and had central venous access, while 3 of these patients also received enteral nutrition. These results are similar to those reported in the literature. Only one of the newly reported patients had received vancomycin therapy before detection of Leuconostoc in the blood, whereas all prior reported cases had previously received this antimicrobial agent. Molecular analysis identified Leuconostoc mesenteroides as the most common species (4 cases) detected. CONCLUSIONS: This report expands on the number of cases of Leuconostoc bacteremia in pediatric patients with short bowel syndrome and shows that prior vancomycin is not a required risk factor for the development of this infection. As previously reported in the literature, the presence of a central venous catheter and disrupted bowel mucosa are risk factors for Leuconostoc bacteremia.

Original languageEnglish (US)
Pages (from-to)1013-1019
Number of pages7
JournalPediatric Infectious Disease Journal
Volume27
Issue number11
DOIs
StatePublished - Nov 1 2008

Fingerprint

Short Bowel Syndrome
Leuconostoc
Bacteremia
Pediatrics
Vancomycin
Central Venous Catheters
Total Parenteral Nutrition
Immunocompromised Host
Enteral Nutrition
Anti-Infective Agents
Infection
Tertiary Care Centers
Teaching
Mucous Membrane
Retrospective Studies

Keywords

  • Bacteremia
  • Leuconostoc
  • Pediatric
  • Short bowel syndrome

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Microbiology (medical)
  • Infectious Diseases

Cite this

Leuconostoc bacteremia in pediatric patients with short bowel syndrome. / Florescu, Diana F; Hill, Lisa; Sudan, Debra; Iwen, Peter Charles.

In: Pediatric Infectious Disease Journal, Vol. 27, No. 11, 01.11.2008, p. 1013-1019.

Research output: Contribution to journalArticle

@article{d02415df323d4d10bcdb91aa9dd2aee6,
title = "Leuconostoc bacteremia in pediatric patients with short bowel syndrome",
abstract = "INTRODUCTION: Infections caused by Leuconostoc species are rare with most reported cases occurring in immunocompromised patients. This article presents 6 new cases of pediatric patients with short bowel syndrome who developed Leuconostoc bacteremia, and compares these cases with those previously reported in the literature. MATERIALS AND METHODS: This is a retrospective, descriptive study (January 2001 to May 2007) performed in a tertiary care teaching center. Hospitalized patients younger than 18 years of age, with multiple positive blood cultures for Leuconostoc spp. were evaluated. The collected data were compared with 10 similar previously reported cases. RESULTS: Six new cases of pediatric patients with short bowel syndrome who developed Leuconostoc bacteremia were identified. All 6 patients had received total parenteral nutrition and had central venous access, while 3 of these patients also received enteral nutrition. These results are similar to those reported in the literature. Only one of the newly reported patients had received vancomycin therapy before detection of Leuconostoc in the blood, whereas all prior reported cases had previously received this antimicrobial agent. Molecular analysis identified Leuconostoc mesenteroides as the most common species (4 cases) detected. CONCLUSIONS: This report expands on the number of cases of Leuconostoc bacteremia in pediatric patients with short bowel syndrome and shows that prior vancomycin is not a required risk factor for the development of this infection. As previously reported in the literature, the presence of a central venous catheter and disrupted bowel mucosa are risk factors for Leuconostoc bacteremia.",
keywords = "Bacteremia, Leuconostoc, Pediatric, Short bowel syndrome",
author = "Florescu, {Diana F} and Lisa Hill and Debra Sudan and Iwen, {Peter Charles}",
year = "2008",
month = "11",
day = "1",
doi = "10.1097/INF.0b013e3181792621",
language = "English (US)",
volume = "27",
pages = "1013--1019",
journal = "Pediatric Infectious Disease Journal",
issn = "0891-3668",
publisher = "Lippincott Williams and Wilkins",
number = "11",

}

TY - JOUR

T1 - Leuconostoc bacteremia in pediatric patients with short bowel syndrome

AU - Florescu, Diana F

AU - Hill, Lisa

AU - Sudan, Debra

AU - Iwen, Peter Charles

PY - 2008/11/1

Y1 - 2008/11/1

N2 - INTRODUCTION: Infections caused by Leuconostoc species are rare with most reported cases occurring in immunocompromised patients. This article presents 6 new cases of pediatric patients with short bowel syndrome who developed Leuconostoc bacteremia, and compares these cases with those previously reported in the literature. MATERIALS AND METHODS: This is a retrospective, descriptive study (January 2001 to May 2007) performed in a tertiary care teaching center. Hospitalized patients younger than 18 years of age, with multiple positive blood cultures for Leuconostoc spp. were evaluated. The collected data were compared with 10 similar previously reported cases. RESULTS: Six new cases of pediatric patients with short bowel syndrome who developed Leuconostoc bacteremia were identified. All 6 patients had received total parenteral nutrition and had central venous access, while 3 of these patients also received enteral nutrition. These results are similar to those reported in the literature. Only one of the newly reported patients had received vancomycin therapy before detection of Leuconostoc in the blood, whereas all prior reported cases had previously received this antimicrobial agent. Molecular analysis identified Leuconostoc mesenteroides as the most common species (4 cases) detected. CONCLUSIONS: This report expands on the number of cases of Leuconostoc bacteremia in pediatric patients with short bowel syndrome and shows that prior vancomycin is not a required risk factor for the development of this infection. As previously reported in the literature, the presence of a central venous catheter and disrupted bowel mucosa are risk factors for Leuconostoc bacteremia.

AB - INTRODUCTION: Infections caused by Leuconostoc species are rare with most reported cases occurring in immunocompromised patients. This article presents 6 new cases of pediatric patients with short bowel syndrome who developed Leuconostoc bacteremia, and compares these cases with those previously reported in the literature. MATERIALS AND METHODS: This is a retrospective, descriptive study (January 2001 to May 2007) performed in a tertiary care teaching center. Hospitalized patients younger than 18 years of age, with multiple positive blood cultures for Leuconostoc spp. were evaluated. The collected data were compared with 10 similar previously reported cases. RESULTS: Six new cases of pediatric patients with short bowel syndrome who developed Leuconostoc bacteremia were identified. All 6 patients had received total parenteral nutrition and had central venous access, while 3 of these patients also received enteral nutrition. These results are similar to those reported in the literature. Only one of the newly reported patients had received vancomycin therapy before detection of Leuconostoc in the blood, whereas all prior reported cases had previously received this antimicrobial agent. Molecular analysis identified Leuconostoc mesenteroides as the most common species (4 cases) detected. CONCLUSIONS: This report expands on the number of cases of Leuconostoc bacteremia in pediatric patients with short bowel syndrome and shows that prior vancomycin is not a required risk factor for the development of this infection. As previously reported in the literature, the presence of a central venous catheter and disrupted bowel mucosa are risk factors for Leuconostoc bacteremia.

KW - Bacteremia

KW - Leuconostoc

KW - Pediatric

KW - Short bowel syndrome

UR - http://www.scopus.com/inward/record.url?scp=58149168894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149168894&partnerID=8YFLogxK

U2 - 10.1097/INF.0b013e3181792621

DO - 10.1097/INF.0b013e3181792621

M3 - Article

VL - 27

SP - 1013

EP - 1019

JO - Pediatric Infectious Disease Journal

JF - Pediatric Infectious Disease Journal

SN - 0891-3668

IS - 11

ER -